Global Seasonal Influenza Vaccines Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Seasonal influenza is an acute viral infection, which can easily spread from person to person. In addition, seasonal influenza occurs during winter and can affect a person of any age group. Vaccination against seasonal influenza is known as seasonal influenza vaccine.
LPI (LP Information)' newest research report, the “Seasonal Influenza Vaccines Industry Forecast” looks at past sales and reviews total world Seasonal Influenza Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Seasonal Influenza Vaccines sales for 2023 through 2029. With Seasonal Influenza Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Seasonal Influenza Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Seasonal Influenza Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Seasonal Influenza Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Seasonal Influenza Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Seasonal Influenza Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Seasonal Influenza Vaccines.
The global Seasonal Influenza Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
The key factor that drives the growth of this market is the increase in incidences of influenza virus globally.
This report presents a comprehensive overview, market shares, and growth opportunities of Seasonal Influenza Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Seasonal Influenza Vaccines market?
What factors are driving Seasonal Influenza Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Seasonal Influenza Vaccines market opportunities vary by end market size?
How does Seasonal Influenza Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Seasonal influenza is an acute viral infection, which can easily spread from person to person. In addition, seasonal influenza occurs during winter and can affect a person of any age group. Vaccination against seasonal influenza is known as seasonal influenza vaccine.
LPI (LP Information)' newest research report, the “Seasonal Influenza Vaccines Industry Forecast” looks at past sales and reviews total world Seasonal Influenza Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Seasonal Influenza Vaccines sales for 2023 through 2029. With Seasonal Influenza Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Seasonal Influenza Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Seasonal Influenza Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Seasonal Influenza Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Seasonal Influenza Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Seasonal Influenza Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Seasonal Influenza Vaccines.
The global Seasonal Influenza Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
The key factor that drives the growth of this market is the increase in incidences of influenza virus globally.
This report presents a comprehensive overview, market shares, and growth opportunities of Seasonal Influenza Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Type A (H1N1)
- Type A (H3N2)
- Type B
- Pediatrics
- Adolescence
- Adults
- Elderly
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GlaxoSmithKline plc
- Sinovac Biotech Ltd
- Changsheng Bio-Technology
- Ccbio SA
- Aleph Biomedical
- Sanofi
- Jiangsu Simcere Vaxtec Bio-pharmaceutical
- Dalian Hissen Bio-pharm
- Abbott Laboratories
- Novartis International AG
What is the 10-year outlook for the global Seasonal Influenza Vaccines market?
What factors are driving Seasonal Influenza Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Seasonal Influenza Vaccines market opportunities vary by end market size?
How does Seasonal Influenza Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Seasonal Influenza Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Seasonal Influenza Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Seasonal Influenza Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Seasonal Influenza Vaccines Segment by Type
2.2.1 Type A (H1N1)
2.2.2 Type A (H3N2)
2.2.3 Type B
2.3 Seasonal Influenza Vaccines Sales by Type
2.3.1 Global Seasonal Influenza Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Seasonal Influenza Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Seasonal Influenza Vaccines Sale Price by Type (2018-2023)
2.4 Seasonal Influenza Vaccines Segment by Application
2.4.1 Pediatrics
2.4.2 Adolescence
2.4.3 Adults
2.4.4 Elderly
2.5 Seasonal Influenza Vaccines Sales by Application
2.5.1 Global Seasonal Influenza Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Seasonal Influenza Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Seasonal Influenza Vaccines Sale Price by Application (2018-2023)
3 GLOBAL SEASONAL INFLUENZA VACCINES BY COMPANY
3.1 Global Seasonal Influenza Vaccines Breakdown Data by Company
3.1.1 Global Seasonal Influenza Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Seasonal Influenza Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Seasonal Influenza Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Seasonal Influenza Vaccines Revenue by Company (2018-2023)
3.2.2 Global Seasonal Influenza Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Seasonal Influenza Vaccines Sale Price by Company
3.4 Key Manufacturers Seasonal Influenza Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Seasonal Influenza Vaccines Product Location Distribution
3.4.2 Players Seasonal Influenza Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SEASONAL INFLUENZA VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Seasonal Influenza Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Seasonal Influenza Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Seasonal Influenza Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Seasonal Influenza Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Seasonal Influenza Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Seasonal Influenza Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Seasonal Influenza Vaccines Sales Growth
4.4 APAC Seasonal Influenza Vaccines Sales Growth
4.5 Europe Seasonal Influenza Vaccines Sales Growth
4.6 Middle East & Africa Seasonal Influenza Vaccines Sales Growth
5 AMERICAS
5.1 Americas Seasonal Influenza Vaccines Sales by Country
5.1.1 Americas Seasonal Influenza Vaccines Sales by Country (2018-2023)
5.1.2 Americas Seasonal Influenza Vaccines Revenue by Country (2018-2023)
5.2 Americas Seasonal Influenza Vaccines Sales by Type
5.3 Americas Seasonal Influenza Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Seasonal Influenza Vaccines Sales by Region
6.1.1 APAC Seasonal Influenza Vaccines Sales by Region (2018-2023)
6.1.2 APAC Seasonal Influenza Vaccines Revenue by Region (2018-2023)
6.2 APAC Seasonal Influenza Vaccines Sales by Type
6.3 APAC Seasonal Influenza Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Seasonal Influenza Vaccines by Country
7.1.1 Europe Seasonal Influenza Vaccines Sales by Country (2018-2023)
7.1.2 Europe Seasonal Influenza Vaccines Revenue by Country (2018-2023)
7.2 Europe Seasonal Influenza Vaccines Sales by Type
7.3 Europe Seasonal Influenza Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Seasonal Influenza Vaccines by Country
8.1.1 Middle East & Africa Seasonal Influenza Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Seasonal Influenza Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Seasonal Influenza Vaccines Sales by Type
8.3 Middle East & Africa Seasonal Influenza Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Seasonal Influenza Vaccines
10.3 Manufacturing Process Analysis of Seasonal Influenza Vaccines
10.4 Industry Chain Structure of Seasonal Influenza Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Seasonal Influenza Vaccines Distributors
11.3 Seasonal Influenza Vaccines Customer
12 WORLD FORECAST REVIEW FOR SEASONAL INFLUENZA VACCINES BY GEOGRAPHIC REGION
12.1 Global Seasonal Influenza Vaccines Market Size Forecast by Region
12.1.1 Global Seasonal Influenza Vaccines Forecast by Region (2024-2029)
12.1.2 Global Seasonal Influenza Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Seasonal Influenza Vaccines Forecast by Type
12.7 Global Seasonal Influenza Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline plc
13.1.1 GlaxoSmithKline plc Company Information
13.1.2 GlaxoSmithKline plc Seasonal Influenza Vaccines Product Portfolios and Specifications
13.1.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GlaxoSmithKline plc Main Business Overview
13.1.5 GlaxoSmithKline plc Latest Developments
13.2 Sinovac Biotech Ltd
13.2.1 Sinovac Biotech Ltd Company Information
13.2.2 Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Portfolios and Specifications
13.2.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sinovac Biotech Ltd Main Business Overview
13.2.5 Sinovac Biotech Ltd Latest Developments
13.3 Changsheng Bio-Technology
13.3.1 Changsheng Bio-Technology Company Information
13.3.2 Changsheng Bio-Technology Seasonal Influenza Vaccines Product Portfolios and Specifications
13.3.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Changsheng Bio-Technology Main Business Overview
13.3.5 Changsheng Bio-Technology Latest Developments
13.4 Ccbio SA
13.4.1 Ccbio SA Company Information
13.4.2 Ccbio SA Seasonal Influenza Vaccines Product Portfolios and Specifications
13.4.3 Ccbio SA Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Ccbio SA Main Business Overview
13.4.5 Ccbio SA Latest Developments
13.5 Aleph Biomedical
13.5.1 Aleph Biomedical Company Information
13.5.2 Aleph Biomedical Seasonal Influenza Vaccines Product Portfolios and Specifications
13.5.3 Aleph Biomedical Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Aleph Biomedical Main Business Overview
13.5.5 Aleph Biomedical Latest Developments
13.6 Sanofi
13.6.1 Sanofi Company Information
13.6.2 Sanofi Seasonal Influenza Vaccines Product Portfolios and Specifications
13.6.3 Sanofi Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sanofi Main Business Overview
13.6.5 Sanofi Latest Developments
13.7 Jiangsu Simcere Vaxtec Bio-pharmaceutical
13.7.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Company Information
13.7.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Portfolios and Specifications
13.7.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Main Business Overview
13.7.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Latest Developments
13.8 Dalian Hissen Bio-pharm
13.8.1 Dalian Hissen Bio-pharm Company Information
13.8.2 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Portfolios and Specifications
13.8.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Dalian Hissen Bio-pharm Main Business Overview
13.8.5 Dalian Hissen Bio-pharm Latest Developments
13.9 Abbott Laboratories
13.9.1 Abbott Laboratories Company Information
13.9.2 Abbott Laboratories Seasonal Influenza Vaccines Product Portfolios and Specifications
13.9.3 Abbott Laboratories Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Abbott Laboratories Main Business Overview
13.9.5 Abbott Laboratories Latest Developments
13.10 Novartis International AG
13.10.1 Novartis International AG Company Information
13.10.2 Novartis International AG Seasonal Influenza Vaccines Product Portfolios and Specifications
13.10.3 Novartis International AG Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Novartis International AG Main Business Overview
13.10.5 Novartis International AG Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Seasonal Influenza Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Seasonal Influenza Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Seasonal Influenza Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Seasonal Influenza Vaccines Segment by Type
2.2.1 Type A (H1N1)
2.2.2 Type A (H3N2)
2.2.3 Type B
2.3 Seasonal Influenza Vaccines Sales by Type
2.3.1 Global Seasonal Influenza Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Seasonal Influenza Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Seasonal Influenza Vaccines Sale Price by Type (2018-2023)
2.4 Seasonal Influenza Vaccines Segment by Application
2.4.1 Pediatrics
2.4.2 Adolescence
2.4.3 Adults
2.4.4 Elderly
2.5 Seasonal Influenza Vaccines Sales by Application
2.5.1 Global Seasonal Influenza Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Seasonal Influenza Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Seasonal Influenza Vaccines Sale Price by Application (2018-2023)
3 GLOBAL SEASONAL INFLUENZA VACCINES BY COMPANY
3.1 Global Seasonal Influenza Vaccines Breakdown Data by Company
3.1.1 Global Seasonal Influenza Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Seasonal Influenza Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Seasonal Influenza Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Seasonal Influenza Vaccines Revenue by Company (2018-2023)
3.2.2 Global Seasonal Influenza Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Seasonal Influenza Vaccines Sale Price by Company
3.4 Key Manufacturers Seasonal Influenza Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Seasonal Influenza Vaccines Product Location Distribution
3.4.2 Players Seasonal Influenza Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SEASONAL INFLUENZA VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Seasonal Influenza Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Seasonal Influenza Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Seasonal Influenza Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Seasonal Influenza Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Seasonal Influenza Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Seasonal Influenza Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Seasonal Influenza Vaccines Sales Growth
4.4 APAC Seasonal Influenza Vaccines Sales Growth
4.5 Europe Seasonal Influenza Vaccines Sales Growth
4.6 Middle East & Africa Seasonal Influenza Vaccines Sales Growth
5 AMERICAS
5.1 Americas Seasonal Influenza Vaccines Sales by Country
5.1.1 Americas Seasonal Influenza Vaccines Sales by Country (2018-2023)
5.1.2 Americas Seasonal Influenza Vaccines Revenue by Country (2018-2023)
5.2 Americas Seasonal Influenza Vaccines Sales by Type
5.3 Americas Seasonal Influenza Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Seasonal Influenza Vaccines Sales by Region
6.1.1 APAC Seasonal Influenza Vaccines Sales by Region (2018-2023)
6.1.2 APAC Seasonal Influenza Vaccines Revenue by Region (2018-2023)
6.2 APAC Seasonal Influenza Vaccines Sales by Type
6.3 APAC Seasonal Influenza Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Seasonal Influenza Vaccines by Country
7.1.1 Europe Seasonal Influenza Vaccines Sales by Country (2018-2023)
7.1.2 Europe Seasonal Influenza Vaccines Revenue by Country (2018-2023)
7.2 Europe Seasonal Influenza Vaccines Sales by Type
7.3 Europe Seasonal Influenza Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Seasonal Influenza Vaccines by Country
8.1.1 Middle East & Africa Seasonal Influenza Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Seasonal Influenza Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Seasonal Influenza Vaccines Sales by Type
8.3 Middle East & Africa Seasonal Influenza Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Seasonal Influenza Vaccines
10.3 Manufacturing Process Analysis of Seasonal Influenza Vaccines
10.4 Industry Chain Structure of Seasonal Influenza Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Seasonal Influenza Vaccines Distributors
11.3 Seasonal Influenza Vaccines Customer
12 WORLD FORECAST REVIEW FOR SEASONAL INFLUENZA VACCINES BY GEOGRAPHIC REGION
12.1 Global Seasonal Influenza Vaccines Market Size Forecast by Region
12.1.1 Global Seasonal Influenza Vaccines Forecast by Region (2024-2029)
12.1.2 Global Seasonal Influenza Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Seasonal Influenza Vaccines Forecast by Type
12.7 Global Seasonal Influenza Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline plc
13.1.1 GlaxoSmithKline plc Company Information
13.1.2 GlaxoSmithKline plc Seasonal Influenza Vaccines Product Portfolios and Specifications
13.1.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GlaxoSmithKline plc Main Business Overview
13.1.5 GlaxoSmithKline plc Latest Developments
13.2 Sinovac Biotech Ltd
13.2.1 Sinovac Biotech Ltd Company Information
13.2.2 Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Portfolios and Specifications
13.2.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sinovac Biotech Ltd Main Business Overview
13.2.5 Sinovac Biotech Ltd Latest Developments
13.3 Changsheng Bio-Technology
13.3.1 Changsheng Bio-Technology Company Information
13.3.2 Changsheng Bio-Technology Seasonal Influenza Vaccines Product Portfolios and Specifications
13.3.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Changsheng Bio-Technology Main Business Overview
13.3.5 Changsheng Bio-Technology Latest Developments
13.4 Ccbio SA
13.4.1 Ccbio SA Company Information
13.4.2 Ccbio SA Seasonal Influenza Vaccines Product Portfolios and Specifications
13.4.3 Ccbio SA Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Ccbio SA Main Business Overview
13.4.5 Ccbio SA Latest Developments
13.5 Aleph Biomedical
13.5.1 Aleph Biomedical Company Information
13.5.2 Aleph Biomedical Seasonal Influenza Vaccines Product Portfolios and Specifications
13.5.3 Aleph Biomedical Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Aleph Biomedical Main Business Overview
13.5.5 Aleph Biomedical Latest Developments
13.6 Sanofi
13.6.1 Sanofi Company Information
13.6.2 Sanofi Seasonal Influenza Vaccines Product Portfolios and Specifications
13.6.3 Sanofi Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sanofi Main Business Overview
13.6.5 Sanofi Latest Developments
13.7 Jiangsu Simcere Vaxtec Bio-pharmaceutical
13.7.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Company Information
13.7.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Portfolios and Specifications
13.7.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Main Business Overview
13.7.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Latest Developments
13.8 Dalian Hissen Bio-pharm
13.8.1 Dalian Hissen Bio-pharm Company Information
13.8.2 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Portfolios and Specifications
13.8.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Dalian Hissen Bio-pharm Main Business Overview
13.8.5 Dalian Hissen Bio-pharm Latest Developments
13.9 Abbott Laboratories
13.9.1 Abbott Laboratories Company Information
13.9.2 Abbott Laboratories Seasonal Influenza Vaccines Product Portfolios and Specifications
13.9.3 Abbott Laboratories Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Abbott Laboratories Main Business Overview
13.9.5 Abbott Laboratories Latest Developments
13.10 Novartis International AG
13.10.1 Novartis International AG Company Information
13.10.2 Novartis International AG Seasonal Influenza Vaccines Product Portfolios and Specifications
13.10.3 Novartis International AG Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Novartis International AG Main Business Overview
13.10.5 Novartis International AG Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Seasonal Influenza Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Seasonal Influenza Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Type A (H1N1)
Table 4. Major Players of Type A (H3N2)
Table 5. Major Players of Type B
Table 6. Global Seasonal Influenza Vaccines Sales by Type (2018-2023) & (K Units)
Table 7. Global Seasonal Influenza Vaccines Sales Market Share by Type (2018-2023)
Table 8. Global Seasonal Influenza Vaccines Revenue by Type (2018-2023) & ($ million)
Table 9. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2023)
Table 10. Global Seasonal Influenza Vaccines Sale Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Seasonal Influenza Vaccines Sales by Application (2018-2023) & (K Units)
Table 12. Global Seasonal Influenza Vaccines Sales Market Share by Application (2018-2023)
Table 13. Global Seasonal Influenza Vaccines Revenue by Application (2018-2023)
Table 14. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2018-2023)
Table 15. Global Seasonal Influenza Vaccines Sale Price by Application (2018-2023) & (USD/Unit)
Table 16. Global Seasonal Influenza Vaccines Sales by Company (2018-2023) & (K Units)
Table 17. Global Seasonal Influenza Vaccines Sales Market Share by Company (2018-2023)
Table 18. Global Seasonal Influenza Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Seasonal Influenza Vaccines Revenue Market Share by Company (2018-2023)
Table 20. Global Seasonal Influenza Vaccines Sale Price by Company (2018-2023) & (USD/Unit)
Table 21. Key Manufacturers Seasonal Influenza Vaccines Producing Area Distribution and Sales Area
Table 22. Players Seasonal Influenza Vaccines Products Offered
Table 23. Seasonal Influenza Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Seasonal Influenza Vaccines Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Seasonal Influenza Vaccines Sales Market Share Geographic Region (2018-2023)
Table 28. Global Seasonal Influenza Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Seasonal Influenza Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Seasonal Influenza Vaccines Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Seasonal Influenza Vaccines Sales Market Share by Country/Region (2018-2023)
Table 32. Global Seasonal Influenza Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Seasonal Influenza Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Seasonal Influenza Vaccines Sales by Country (2018-2023) & (K Units)
Table 35. Americas Seasonal Influenza Vaccines Sales Market Share by Country (2018-2023)
Table 36. Americas Seasonal Influenza Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Seasonal Influenza Vaccines Revenue Market Share by Country (2018-2023)
Table 38. Americas Seasonal Influenza Vaccines Sales by Type (2018-2023) & (K Units)
Table 39. Americas Seasonal Influenza Vaccines Sales by Application (2018-2023) & (K Units)
Table 40. APAC Seasonal Influenza Vaccines Sales by Region (2018-2023) & (K Units)
Table 41. APAC Seasonal Influenza Vaccines Sales Market Share by Region (2018-2023)
Table 42. APAC Seasonal Influenza Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Seasonal Influenza Vaccines Revenue Market Share by Region (2018-2023)
Table 44. APAC Seasonal Influenza Vaccines Sales by Type (2018-2023) & (K Units)
Table 45. APAC Seasonal Influenza Vaccines Sales by Application (2018-2023) & (K Units)
Table 46. Europe Seasonal Influenza Vaccines Sales by Country (2018-2023) & (K Units)
Table 47. Europe Seasonal Influenza Vaccines Sales Market Share by Country (2018-2023)
Table 48. Europe Seasonal Influenza Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Seasonal Influenza Vaccines Revenue Market Share by Country (2018-2023)
Table 50. Europe Seasonal Influenza Vaccines Sales by Type (2018-2023) & (K Units)
Table 51. Europe Seasonal Influenza Vaccines Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Seasonal Influenza Vaccines Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Seasonal Influenza Vaccines Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Seasonal Influenza Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Seasonal Influenza Vaccines Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Seasonal Influenza Vaccines Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Seasonal Influenza Vaccines Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Seasonal Influenza Vaccines
Table 59. Key Market Challenges & Risks of Seasonal Influenza Vaccines
Table 60. Key Industry Trends of Seasonal Influenza Vaccines
Table 61. Seasonal Influenza Vaccines Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Seasonal Influenza Vaccines Distributors List
Table 64. Seasonal Influenza Vaccines Customer List
Table 65. Global Seasonal Influenza Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Seasonal Influenza Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Seasonal Influenza Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Seasonal Influenza Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Seasonal Influenza Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Seasonal Influenza Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Seasonal Influenza Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Seasonal Influenza Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Seasonal Influenza Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Seasonal Influenza Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Seasonal Influenza Vaccines Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Seasonal Influenza Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Seasonal Influenza Vaccines Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Seasonal Influenza Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. GlaxoSmithKline plc Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 80. GlaxoSmithKline plc Seasonal Influenza Vaccines Product Portfolios and Specifications
Table 81. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. GlaxoSmithKline plc Main Business
Table 83. GlaxoSmithKline plc Latest Developments
Table 84. Sinovac Biotech Ltd Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 85. Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Portfolios and Specifications
Table 86. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Sinovac Biotech Ltd Main Business
Table 88. Sinovac Biotech Ltd Latest Developments
Table 89. Changsheng Bio-Technology Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 90. Changsheng Bio-Technology Seasonal Influenza Vaccines Product Portfolios and Specifications
Table 91. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Changsheng Bio-Technology Main Business
Table 93. Changsheng Bio-Technology Latest Developments
Table 94. Ccbio SA Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. Ccbio SA Seasonal Influenza Vaccines Product Portfolios and Specifications
Table 96. Ccbio SA Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Ccbio SA Main Business
Table 98. Ccbio SA Latest Developments
Table 99. Aleph Biomedical Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. Aleph Biomedical Seasonal Influenza Vaccines Product Portfolios and Specifications
Table 101. Aleph Biomedical Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Aleph Biomedical Main Business
Table 103. Aleph Biomedical Latest Developments
Table 104. Sanofi Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. Sanofi Seasonal Influenza Vaccines Product Portfolios and Specifications
Table 106. Sanofi Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Sanofi Main Business
Table 108. Sanofi Latest Developments
Table 109. Jiangsu Simcere Vaxtec Bio-pharmaceutical Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 110. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Portfolios and Specifications
Table 111. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Jiangsu Simcere Vaxtec Bio-pharmaceutical Main Business
Table 113. Jiangsu Simcere Vaxtec Bio-pharmaceutical Latest Developments
Table 114. Dalian Hissen Bio-pharm Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 115. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Portfolios and Specifications
Table 116. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Dalian Hissen Bio-pharm Main Business
Table 118. Dalian Hissen Bio-pharm Latest Developments
Table 119. Abbott Laboratories Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 120. Abbott Laboratories Seasonal Influenza Vaccines Product Portfolios and Specifications
Table 121. Abbott Laboratories Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Abbott Laboratories Main Business
Table 123. Abbott Laboratories Latest Developments
Table 124. Novartis International AG Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 125. Novartis International AG Seasonal Influenza Vaccines Product Portfolios and Specifications
Table 126. Novartis International AG Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Novartis International AG Main Business
Table 128. Novartis International AG Latest Developments
Table 1. Seasonal Influenza Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Seasonal Influenza Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Type A (H1N1)
Table 4. Major Players of Type A (H3N2)
Table 5. Major Players of Type B
Table 6. Global Seasonal Influenza Vaccines Sales by Type (2018-2023) & (K Units)
Table 7. Global Seasonal Influenza Vaccines Sales Market Share by Type (2018-2023)
Table 8. Global Seasonal Influenza Vaccines Revenue by Type (2018-2023) & ($ million)
Table 9. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2023)
Table 10. Global Seasonal Influenza Vaccines Sale Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Seasonal Influenza Vaccines Sales by Application (2018-2023) & (K Units)
Table 12. Global Seasonal Influenza Vaccines Sales Market Share by Application (2018-2023)
Table 13. Global Seasonal Influenza Vaccines Revenue by Application (2018-2023)
Table 14. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2018-2023)
Table 15. Global Seasonal Influenza Vaccines Sale Price by Application (2018-2023) & (USD/Unit)
Table 16. Global Seasonal Influenza Vaccines Sales by Company (2018-2023) & (K Units)
Table 17. Global Seasonal Influenza Vaccines Sales Market Share by Company (2018-2023)
Table 18. Global Seasonal Influenza Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Seasonal Influenza Vaccines Revenue Market Share by Company (2018-2023)
Table 20. Global Seasonal Influenza Vaccines Sale Price by Company (2018-2023) & (USD/Unit)
Table 21. Key Manufacturers Seasonal Influenza Vaccines Producing Area Distribution and Sales Area
Table 22. Players Seasonal Influenza Vaccines Products Offered
Table 23. Seasonal Influenza Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Seasonal Influenza Vaccines Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Seasonal Influenza Vaccines Sales Market Share Geographic Region (2018-2023)
Table 28. Global Seasonal Influenza Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Seasonal Influenza Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Seasonal Influenza Vaccines Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Seasonal Influenza Vaccines Sales Market Share by Country/Region (2018-2023)
Table 32. Global Seasonal Influenza Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Seasonal Influenza Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Seasonal Influenza Vaccines Sales by Country (2018-2023) & (K Units)
Table 35. Americas Seasonal Influenza Vaccines Sales Market Share by Country (2018-2023)
Table 36. Americas Seasonal Influenza Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Seasonal Influenza Vaccines Revenue Market Share by Country (2018-2023)
Table 38. Americas Seasonal Influenza Vaccines Sales by Type (2018-2023) & (K Units)
Table 39. Americas Seasonal Influenza Vaccines Sales by Application (2018-2023) & (K Units)
Table 40. APAC Seasonal Influenza Vaccines Sales by Region (2018-2023) & (K Units)
Table 41. APAC Seasonal Influenza Vaccines Sales Market Share by Region (2018-2023)
Table 42. APAC Seasonal Influenza Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Seasonal Influenza Vaccines Revenue Market Share by Region (2018-2023)
Table 44. APAC Seasonal Influenza Vaccines Sales by Type (2018-2023) & (K Units)
Table 45. APAC Seasonal Influenza Vaccines Sales by Application (2018-2023) & (K Units)
Table 46. Europe Seasonal Influenza Vaccines Sales by Country (2018-2023) & (K Units)
Table 47. Europe Seasonal Influenza Vaccines Sales Market Share by Country (2018-2023)
Table 48. Europe Seasonal Influenza Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Seasonal Influenza Vaccines Revenue Market Share by Country (2018-2023)
Table 50. Europe Seasonal Influenza Vaccines Sales by Type (2018-2023) & (K Units)
Table 51. Europe Seasonal Influenza Vaccines Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Seasonal Influenza Vaccines Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Seasonal Influenza Vaccines Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Seasonal Influenza Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Seasonal Influenza Vaccines Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Seasonal Influenza Vaccines Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Seasonal Influenza Vaccines Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Seasonal Influenza Vaccines
Table 59. Key Market Challenges & Risks of Seasonal Influenza Vaccines
Table 60. Key Industry Trends of Seasonal Influenza Vaccines
Table 61. Seasonal Influenza Vaccines Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Seasonal Influenza Vaccines Distributors List
Table 64. Seasonal Influenza Vaccines Customer List
Table 65. Global Seasonal Influenza Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Seasonal Influenza Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Seasonal Influenza Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Seasonal Influenza Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Seasonal Influenza Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Seasonal Influenza Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Seasonal Influenza Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Seasonal Influenza Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Seasonal Influenza Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Seasonal Influenza Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Seasonal Influenza Vaccines Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Seasonal Influenza Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Seasonal Influenza Vaccines Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Seasonal Influenza Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. GlaxoSmithKline plc Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 80. GlaxoSmithKline plc Seasonal Influenza Vaccines Product Portfolios and Specifications
Table 81. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. GlaxoSmithKline plc Main Business
Table 83. GlaxoSmithKline plc Latest Developments
Table 84. Sinovac Biotech Ltd Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 85. Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Portfolios and Specifications
Table 86. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Sinovac Biotech Ltd Main Business
Table 88. Sinovac Biotech Ltd Latest Developments
Table 89. Changsheng Bio-Technology Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 90. Changsheng Bio-Technology Seasonal Influenza Vaccines Product Portfolios and Specifications
Table 91. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Changsheng Bio-Technology Main Business
Table 93. Changsheng Bio-Technology Latest Developments
Table 94. Ccbio SA Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. Ccbio SA Seasonal Influenza Vaccines Product Portfolios and Specifications
Table 96. Ccbio SA Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Ccbio SA Main Business
Table 98. Ccbio SA Latest Developments
Table 99. Aleph Biomedical Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. Aleph Biomedical Seasonal Influenza Vaccines Product Portfolios and Specifications
Table 101. Aleph Biomedical Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Aleph Biomedical Main Business
Table 103. Aleph Biomedical Latest Developments
Table 104. Sanofi Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. Sanofi Seasonal Influenza Vaccines Product Portfolios and Specifications
Table 106. Sanofi Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Sanofi Main Business
Table 108. Sanofi Latest Developments
Table 109. Jiangsu Simcere Vaxtec Bio-pharmaceutical Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 110. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Portfolios and Specifications
Table 111. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Jiangsu Simcere Vaxtec Bio-pharmaceutical Main Business
Table 113. Jiangsu Simcere Vaxtec Bio-pharmaceutical Latest Developments
Table 114. Dalian Hissen Bio-pharm Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 115. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Portfolios and Specifications
Table 116. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Dalian Hissen Bio-pharm Main Business
Table 118. Dalian Hissen Bio-pharm Latest Developments
Table 119. Abbott Laboratories Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 120. Abbott Laboratories Seasonal Influenza Vaccines Product Portfolios and Specifications
Table 121. Abbott Laboratories Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Abbott Laboratories Main Business
Table 123. Abbott Laboratories Latest Developments
Table 124. Novartis International AG Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 125. Novartis International AG Seasonal Influenza Vaccines Product Portfolios and Specifications
Table 126. Novartis International AG Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Novartis International AG Main Business
Table 128. Novartis International AG Latest Developments
LIST OF FIGURES
Figure 1. Picture of Seasonal Influenza Vaccines
Figure 2. Seasonal Influenza Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Seasonal Influenza Vaccines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Seasonal Influenza Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Seasonal Influenza Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Type A (H1N1)
Figure 10. Product Picture of Type A (H3N2)
Figure 11. Product Picture of Type B
Figure 12. Global Seasonal Influenza Vaccines Sales Market Share by Type in 2022
Figure 13. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2023)
Figure 14. Seasonal Influenza Vaccines Consumed in Pediatrics
Figure 15. Global Seasonal Influenza Vaccines Market: Pediatrics (2018-2023) & (K Units)
Figure 16. Seasonal Influenza Vaccines Consumed in Adolescence
Figure 17. Global Seasonal Influenza Vaccines Market: Adolescence (2018-2023) & (K Units)
Figure 18. Seasonal Influenza Vaccines Consumed in Adults
Figure 19. Global Seasonal Influenza Vaccines Market: Adults (2018-2023) & (K Units)
Figure 20. Seasonal Influenza Vaccines Consumed in Elderly
Figure 21. Global Seasonal Influenza Vaccines Market: Elderly (2018-2023) & (K Units)
Figure 22. Global Seasonal Influenza Vaccines Sales Market Share by Application (2022)
Figure 23. Global Seasonal Influenza Vaccines Revenue Market Share by Application in 2022
Figure 24. Seasonal Influenza Vaccines Sales Market by Company in 2022 (K Units)
Figure 25. Global Seasonal Influenza Vaccines Sales Market Share by Company in 2022
Figure 26. Seasonal Influenza Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Seasonal Influenza Vaccines Revenue Market Share by Company in 2022
Figure 28. Global Seasonal Influenza Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Seasonal Influenza Vaccines Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Seasonal Influenza Vaccines Sales 2018-2023 (K Units)
Figure 31. Americas Seasonal Influenza Vaccines Revenue 2018-2023 ($ Millions)
Figure 32. APAC Seasonal Influenza Vaccines Sales 2018-2023 (K Units)
Figure 33. APAC Seasonal Influenza Vaccines Revenue 2018-2023 ($ Millions)
Figure 34. Europe Seasonal Influenza Vaccines Sales 2018-2023 (K Units)
Figure 35. Europe Seasonal Influenza Vaccines Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Seasonal Influenza Vaccines Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Seasonal Influenza Vaccines Revenue 2018-2023 ($ Millions)
Figure 38. Americas Seasonal Influenza Vaccines Sales Market Share by Country in 2022
Figure 39. Americas Seasonal Influenza Vaccines Revenue Market Share by Country in 2022
Figure 40. Americas Seasonal Influenza Vaccines Sales Market Share by Type (2018-2023)
Figure 41. Americas Seasonal Influenza Vaccines Sales Market Share by Application (2018-2023)
Figure 42. United States Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Seasonal Influenza Vaccines Sales Market Share by Region in 2022
Figure 47. APAC Seasonal Influenza Vaccines Revenue Market Share by Regions in 2022
Figure 48. APAC Seasonal Influenza Vaccines Sales Market Share by Type (2018-2023)
Figure 49. APAC Seasonal Influenza Vaccines Sales Market Share by Application (2018-2023)
Figure 50. China Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Seasonal Influenza Vaccines Sales Market Share by Country in 2022
Figure 58. Europe Seasonal Influenza Vaccines Revenue Market Share by Country in 2022
Figure 59. Europe Seasonal Influenza Vaccines Sales Market Share by Type (2018-2023)
Figure 60. Europe Seasonal Influenza Vaccines Sales Market Share by Application (2018-2023)
Figure 61. Germany Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Seasonal Influenza Vaccines Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Seasonal Influenza Vaccines Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Seasonal Influenza Vaccines Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Seasonal Influenza Vaccines Sales Market Share by Application (2018-2023)
Figure 70. Egypt Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Seasonal Influenza Vaccines in 2022
Figure 76. Manufacturing Process Analysis of Seasonal Influenza Vaccines
Figure 77. Industry Chain Structure of Seasonal Influenza Vaccines
Figure 78. Channels of Distribution
Figure 79. Global Seasonal Influenza Vaccines Sales Market Forecast by Region (2024-2029)
Figure 80. Global Seasonal Influenza Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Seasonal Influenza Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Seasonal Influenza Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Seasonal Influenza Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Seasonal Influenza Vaccines Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Seasonal Influenza Vaccines
Figure 2. Seasonal Influenza Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Seasonal Influenza Vaccines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Seasonal Influenza Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Seasonal Influenza Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Type A (H1N1)
Figure 10. Product Picture of Type A (H3N2)
Figure 11. Product Picture of Type B
Figure 12. Global Seasonal Influenza Vaccines Sales Market Share by Type in 2022
Figure 13. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2023)
Figure 14. Seasonal Influenza Vaccines Consumed in Pediatrics
Figure 15. Global Seasonal Influenza Vaccines Market: Pediatrics (2018-2023) & (K Units)
Figure 16. Seasonal Influenza Vaccines Consumed in Adolescence
Figure 17. Global Seasonal Influenza Vaccines Market: Adolescence (2018-2023) & (K Units)
Figure 18. Seasonal Influenza Vaccines Consumed in Adults
Figure 19. Global Seasonal Influenza Vaccines Market: Adults (2018-2023) & (K Units)
Figure 20. Seasonal Influenza Vaccines Consumed in Elderly
Figure 21. Global Seasonal Influenza Vaccines Market: Elderly (2018-2023) & (K Units)
Figure 22. Global Seasonal Influenza Vaccines Sales Market Share by Application (2022)
Figure 23. Global Seasonal Influenza Vaccines Revenue Market Share by Application in 2022
Figure 24. Seasonal Influenza Vaccines Sales Market by Company in 2022 (K Units)
Figure 25. Global Seasonal Influenza Vaccines Sales Market Share by Company in 2022
Figure 26. Seasonal Influenza Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Seasonal Influenza Vaccines Revenue Market Share by Company in 2022
Figure 28. Global Seasonal Influenza Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Seasonal Influenza Vaccines Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Seasonal Influenza Vaccines Sales 2018-2023 (K Units)
Figure 31. Americas Seasonal Influenza Vaccines Revenue 2018-2023 ($ Millions)
Figure 32. APAC Seasonal Influenza Vaccines Sales 2018-2023 (K Units)
Figure 33. APAC Seasonal Influenza Vaccines Revenue 2018-2023 ($ Millions)
Figure 34. Europe Seasonal Influenza Vaccines Sales 2018-2023 (K Units)
Figure 35. Europe Seasonal Influenza Vaccines Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Seasonal Influenza Vaccines Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Seasonal Influenza Vaccines Revenue 2018-2023 ($ Millions)
Figure 38. Americas Seasonal Influenza Vaccines Sales Market Share by Country in 2022
Figure 39. Americas Seasonal Influenza Vaccines Revenue Market Share by Country in 2022
Figure 40. Americas Seasonal Influenza Vaccines Sales Market Share by Type (2018-2023)
Figure 41. Americas Seasonal Influenza Vaccines Sales Market Share by Application (2018-2023)
Figure 42. United States Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Seasonal Influenza Vaccines Sales Market Share by Region in 2022
Figure 47. APAC Seasonal Influenza Vaccines Revenue Market Share by Regions in 2022
Figure 48. APAC Seasonal Influenza Vaccines Sales Market Share by Type (2018-2023)
Figure 49. APAC Seasonal Influenza Vaccines Sales Market Share by Application (2018-2023)
Figure 50. China Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Seasonal Influenza Vaccines Sales Market Share by Country in 2022
Figure 58. Europe Seasonal Influenza Vaccines Revenue Market Share by Country in 2022
Figure 59. Europe Seasonal Influenza Vaccines Sales Market Share by Type (2018-2023)
Figure 60. Europe Seasonal Influenza Vaccines Sales Market Share by Application (2018-2023)
Figure 61. Germany Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Seasonal Influenza Vaccines Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Seasonal Influenza Vaccines Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Seasonal Influenza Vaccines Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Seasonal Influenza Vaccines Sales Market Share by Application (2018-2023)
Figure 70. Egypt Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Seasonal Influenza Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Seasonal Influenza Vaccines in 2022
Figure 76. Manufacturing Process Analysis of Seasonal Influenza Vaccines
Figure 77. Industry Chain Structure of Seasonal Influenza Vaccines
Figure 78. Channels of Distribution
Figure 79. Global Seasonal Influenza Vaccines Sales Market Forecast by Region (2024-2029)
Figure 80. Global Seasonal Influenza Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Seasonal Influenza Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Seasonal Influenza Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Seasonal Influenza Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Seasonal Influenza Vaccines Revenue Market Share Forecast by Application (2024-2029)
